Company Monitoring Page for Vivus

latest headlines for company on cafepharma

ADA Meeting 2009: Novel Diabetes Therapies Presented
Seeking Alpha
Wed, 06/24/09 - 07:56 am
Tags:
diabetes, Amylin, Arena Pharmaceuticals, Halozyme, Isis Pharmaceuticals, Pfizer, Eli Lilly, Novo Nordisk, Xoma, Roche, Vivus
NeuroSearch: Experimental Obesity Drug to Begin Phase 3 Trials
Seeking Alpha
Wed, 06/10/09 - 08:26 am
Tags:
Neurosearch, obesity, Arena Pharmaceuticals, drug trials, Vivus, Orexigen, tesofensine
Arena, The Aftermath
Seeking Alpha
Thu, 04/2/09 - 07:18 am
Tags:
Arena Pharmaceuticals, obesity, Vivus, Orexigen, Contrave, Qnexa
Obesity Drug Arena's Heavy Burden
TheStreet.com
Mon, 03/23/09 - 09:42 am
Tags:
obesity, Arena Pharmaceuticals, Vivus, fen phen, Orexigen, Wyeth, lorcaserin
GlaxoSmithKline's New Ally For Alli
CNBC
Fri, 03/20/09 - 11:47 am
Tags:
GSK, Alli, obesity, Arena Pharmaceuticals, Vivus
Three Ways to Play Arena Pharmaceuticals
Seeking Alpha
Wed, 03/18/09 - 08:35 am
Tags:
Arena Pharmaceuticals, obesity, Vivus, Contrave
Take Advantage of Market Confusion to Buy Orexigen Therapeutics
Seeking Alpha
Tue, 03/17/09 - 09:25 am
Tags:
obesity, Orexigen, Contrave, Empatic, Eli Lilly, Arena Pharmaceuticals, Vivus
Four Weighty Reasons to Invest in Vivus
Seeking Alpha
Wed, 03/11/09 - 07:50 am
Tags:
Vivus, Qnexa, obesity
Arena Pharmaceuticals: Near Term Gamble May Be Worth It
Seeking Alpha
Tue, 03/10/09 - 07:34 am
Tags:
Arena Pharmaceuticals, obesity, Qnexa, Vivus, Orexigen, Contrave, lorcaserin
Vivus: A Bet on Well-Funded, Late-Stage Pipeline 3 comments
Seeking Alpha
Wed, 03/4/09 - 09:18 am
Tags:
Vivus, pipelines, obesity, Arena Pharmaceuticals, Orexigen
Orexigen to Post Obesity Data in Race With Vivus, Arena
TheStreet.com
Tue, 01/6/09 - 04:51 pm
Tags:
Orexigen, obesity, Vivus, Arena Pharmaceuticals, Contrave, Qnexa

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.